NanoMedicine International Conference 2019

NanoMed 2019
23 Oct - 25 Oct 2019 | Lisbon - Portugal
Conference Speakers
Keynote Speakers
1563914278_ProfRogerioGaspar.jpg
University of Lisbon, Portugal

Rogério Gaspar (RG) is a Full Professor at the Faculty of Pharmacy at the University of Lisboa (FFUL), previously the Vice-Rector/Pro-Rector for Research, Entrepreneurship and Knowledge Transfer at the University of Lisboa, ULisboa (July 2013 – September 2016 and October 2016 – September 2017) and currently the President of the Portuguese Society of Pharmaceutical Sciences (SPCF). Since 2017 he is a foreign...

More

Rogério Gaspar (RG) is a Full Professor at the Faculty of Pharmacy at the University of Lisboa (FFUL), previously the Vice-Rector/Pro-Rector for Research, Entrepreneurship and Knowledge Transfer at the University of Lisboa, ULisboa (July 2013 – September 2016 and October 2016 – September 2017) and currently the President of the Portuguese Society of Pharmaceutical Sciences (SPCF). Since 2017 he is a foreign member of the Royal Academy of Pharmacy (RANF, Spain). He also represents FFUL at the coordination of OPSS (Portuguese Observatory for Health Systems).

 

At the University of Lisbon (where he moved after being at the University of Coimbra from 1985 to 2006) he was the coordinator for the Pharmaceutical Technology sector (2007-2011 and 2011-2013), and also the coordinator (2007-2013) of the Nanomedicine & Drug Delivery Systems research group (Nano&DDS, ~60 researchers) within the Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL) which he co-founded in 2007. Current research interests include the development of new therapeutic strategies using liposomes, polymeric biodegradable nanoparticles, and polymer therapeutics, with the main focus oriented towards cytosolic delivery of nucleic acids and use of targeted delivery systems for combination therapy or therapeutic vaccines in cancer.

 

He was also Sub-director FFUL / Vice-Dean FFUL (2012-2013), an elected member of the Scientific Council and Faculty Assembly of FFUL (2009-2013 and 2018-2022) and was also a member of the General Council of the University of Lisbon (2008-2013). Since June 2015, RG integrates the Department of Social Pharmacy at FFUL and was elected its President in February 2017 and re-elected for the next 4 years in July 2018. From May 1st, 2017 he become a researcher at the Institute of Bioengineering and Biosciences (iBB) of the University of Lisbon.

 

After graduation as a pharmacist from the University of Coimbra (Portugal) in 1985, Rogério Gaspar obtained his PhD in Pharmaceutical Sciences from the Catholic University of Louvain (Belgium) in 1991, for his research on the development of bioerodible polymeric nanoparticles for delivery of anti-Leishmaniasis chemotherapy. On return to the University of Coimbra he started the Colloidal Drug Carriers Unit (1993) within the Centre for Neurosciences and Cell Biology at Coimbra (CNC). The main research interests where nanoparticle-macrophage interactions, imaging systems for MRI, nanoparticulate ocular drug delivery, brain delivery, cancer targeted therapeutics using stealth-targeted liposomes and cytosolic delivery of nucleic acids using different cationic or pH sensitive systems. At that moment he became involved in the development of European Research Networks for advanced training (e.g. initiator and first coordinator of the Galenos network, 1993-1996) and served as president of the Spanish-Portuguese Local Chapter of the Controlled Release Society (2002-2005).

 

Between 1995 to 2002, in parallel with his research activities in academia, he became involved as expert and member of the Portuguese medicines evaluation board (INFARMED; and from Jan 2000-July 2002 as Vice-Chairman of the Management Board at INFARMED). He also became involved with the European Medicines Agency (now EMA) where he served on several committees (incl. CPMP now CHMP), he was a member of the Management Board, and of expert groups of the European Council of Ministers and European Commission. He was the coordinator of the working group that concluded the approval at Council of Ministers level for the European Directive in Clinical Trials (2000) and participated in the initial steps of the mutual recognition between Japan and EU in the pharmaceutical sector (2002). Further positions as expert to INFARMED (2008-2011) and the newly formed Ad-hoc expert group in Nanomedicines to EMA (2009-2011) until 2011. He has also held posts as an external consultant with a role of coordination and overview on the research activities of the Portuguese pharmaceutical company Tecnimede (2002-2008), as a consultant to ASEAN countries in the context of a EU cooperation programme (2005-2006), and was a consultant/training advisor to a number of pharmaceutical companies including Cell Therapeutics Inc. (Seattle, USA), Fresenius (Bad Homburg, Germany), Zcube s.r.l. (Milano, Italy), TEVA (Israel) and Cellator (Vancouver, Canada). He was also member of the SAB of the EPSRC (UK) Platform in Nanomedicines (2007 and 2008), has been member of the EAB of EuroNanoMed-I and II (ERA-NET) (since 2009) and participated as a member of the SAB of the Spanish CIBBER-BBN (2010-2013). Since 2007 also participated as an external reviewer for research programmes in nanotechnology/nanomedicine /medicines research in Spain (Ministry of Industry, Inst. Carlos III), Norway (Norges forskningsråd), Austria (FWF) and South Africa (CSIR).

 

Rogério Gaspar was heavily involved in the elaboration and implementation of the European Science Foundation's (ESF) “Forward Look in Nanomedicine”, as Co-chair/chair of two ESF Nanomedicine Research Conferences in Sant Feliu (2006 and 2008), and Chair of the ESF Summer School Nanomedicine Lisbon (2009).

Participated as one the members of the expert-panel in the establishment of the “Pharmaceutical Sciences 2020” strategic roadmap of FIP (http://www.sciencedirect.com/science/article/pii/S0928098709002139 ) and contributed to the “NanoMed Round Table: a report on the nanomedicine economic, regulatory, ethical and social environment” (http://www.philosophie.tu-darmstadt.de/media/institut_fuer_philosophie/diesunddas/nordmann/nanomed.pdf ), part of a FP7 project looking at positioning Nanomedicine in Europe.

 

Rogério was elected (2009-2013; and again in 2016-2018 and 2019-2020) as a member of the Executive Committee of the European Federation for Pharmaceutical Sciences (EUFEPS) acting also as Vice-President of EUFEPS (2011-2012 and again from January 2019). In that capacity he previously coordinated its position paper (http://www.sciencedirect.com/science/article/pii/S092809871200382X) in Science Policy looking up at Horizon2020 for an European Medicines Research Agenda. From 2016, he has under his responsibilities at EUFEPS ExCo the topics in Science Policy, European Affairs and Regulatory Science, coordinating also the EUFEPS Network in Regulatory Science.

Less
1556887189_Prof-Daniela-Iannazzo.jpg
Department of Engineering, University of Messina, Italy

Daniela Iannazzo graduated in Chemistry and Pharmaceutical Technology at the University of Messina in 1995.

In 1999 she obtained the PhD qualification in Pharmaceutical Sciences and in 2001, the postgraduate qualification in Applied Microbiology at the University of Messina.

In 2001 she received a four years research contract at the University of Messina for the design, characterization and...

More

Daniela Iannazzo graduated in Chemistry and Pharmaceutical Technology at the University of Messina in 1995.

In 1999 she obtained the PhD qualification in Pharmaceutical Sciences and in 2001, the postgraduate qualification in Applied Microbiology at the University of Messina.

In 2001 she received a four years research contract at the University of Messina for the design, characterization and vehiculation of antivirals possessing a modified nucleosidic structure.

In 2003 she was Visiting Professor at the Departamento de Quimica Asimmetrica of the Faculty of Science at the University of Zaragoza and she was interested to the asymmetric synthesis of new modified nucleosides and to the application of quantomechanical calculations for the rationalization of pericyclic reactions.

In 2006 she became University Researcher in Organic Chemistry at the University of Messina.

In 2011 she performed research activity at the Department of Pharmaceutical Sciences of the University of Trieste; the research activity regarded the organic functionalization of nanostructured materials for biomedical applications.

In 2018 she became Associate Professor in Organic Chemistry at the Department of Engineering of the University of Messina.

From 2019, she is member of the Doctoral Course in Bioengineering Applied to Medical Sciences of the University of Messina.

Daniela Iannazzo is author of 80 international publications on highly qualified international journals and 4 book chapters with H-index of 28 and number of citations greater than 1700 (font SCOPUS, May 2019). She is also author of  2 patents, one of which is an international patent.

Less
1554772675_ProfPedroAlpuim.jpg
International Iberian Nanotechnology Laboratory, Portugal

Pedro Alpuim is group leader in 2D Materials and Devices at INL. He works in CVD and 2D materials device fabrication, with the emphasis in biosensors. In particular, he develops graphene devices to detect biomarkers for medicine and for environmental monitoring. Optoelectronic devices based on transition-metal di-chalcogenides for light detection and solar energy conversion are also within his research interests.

P. Alpuim is...

More

Pedro Alpuim is group leader in 2D Materials and Devices at INL. He works in CVD and 2D materials device fabrication, with the emphasis in biosensors. In particular, he develops graphene devices to detect biomarkers for medicine and for environmental monitoring. Optoelectronic devices based on transition-metal di-chalcogenides for light detection and solar energy conversion are also within his research interests.

P. Alpuim is a professor in the Physics Department of the University of Minho (UM), where he teaches graduate and undergraduate courses on the physics of electronic devices, nanotechnology, and clean-room fabrication.

He received a PhD degree in Materials Engineering from IST Lisbon in 2003, working in amorphous silicon thin film devices for flexible electronics, and a Master degree in Physics from the UM. He installed a thin-film laboratory at UM where he focused on fabrication of thin-film silicon solar cells, piezoresistive sensor arrays for health care, and thermoelectric junctions of telluride compounds for micro-cooling and energy scavenging. He published more than 80 papers in peer-reviewed journals and has h-index=22.

Less
1560347186_DrSilviaPanseri.jpg
Institute of Science and Technology for Ceramics, National Research Council of Italy - ISTEC-CNR, Italy

Dr. Panseri has been trained on different topics in internationally renowned institutes such as University of Milano Bicocca and San Raffaele Scientific Institute (Stem Cell Research Institute) in Italy, Brain Research Institute of the Swiss Federal Institute of Technology Zurich (ETH) and University of Zurich, Columbia University (Dep. of Biomedical Engineering, New York). Her research activity has always been characterized by a multi and interdisciplinary approach,...

More

Dr. Panseri has been trained on different topics in internationally renowned institutes such as University of Milano Bicocca and San Raffaele Scientific Institute (Stem Cell Research Institute) in Italy, Brain Research Institute of the Swiss Federal Institute of Technology Zurich (ETH) and University of Zurich, Columbia University (Dep. of Biomedical Engineering, New York). Her research activity has always been characterized by a multi and interdisciplinary approach, at the interfaces between nanotechnology and regenerative medicine. Her interests are focused on novel approaches in tissue engineering and nanomedicine, and she had acquired expertise in 3D stem cell culture with several nanobiomaterials and in vivo regenerative medicine. She was awarded the SIBS award for “Best PhD Thesis of 2009 in Biological Field”.

In 2010 she moved to the Institute of Science and Technology for Ceramics, National Research Council of Italy. She set up the first Cell/Biomaterial Interaction Lab of the Institute that she still manages. In the last years she has been involved as key personnel in several Eu projects (SCREENED - H2020‐SC1‐BHC-27‐2018‐825745. BioTechMA ‐ 2014‐1‐IT02‐KA203‐003482. MAGISTER ‐ NMP3‐LA‐2008‐214685. OPHIS ‐ FP7‐NMP‐2009‐SMALL‐3‐246373. SMILEY ‐ NMP4‐SL‐2012‐310637).

She is co-inventor of 2 patents, she has been trained in BioEntrepreneurship (Advanced short course on BioBusiness - Swiss University in Lugano; Business Planning Bootcamp - EIT RawMaterials, Anacapri), and in 2013 she was awarded “Best Research Ideas” for the Market Competition (Second Prize): “Magnetic Bioactive and Biodegradable Micro‐Nano beads” at MiMe International Conference. Author of more than 60 papers published in international peer‐reviewed journals, 12 book chapters, H‐index 21, co‐editor of the eBook 'Biomimetic approaches for tissue healing'. Guest Editor of several Special Issues in peer‐reviewed journals.

Less
1563914866_ProfNunoSantos.jpg
Group Leader at iMM Lisboa, Lisbon, Portugal

Nuno Correia Santos was born on July 17, 1972, in Lisbon, Portugal. In July, 1995, he received his 5-years degree in Biochemistry from the Faculty of Sciences, University of Lisbon. From 1994 to 1999, he worked as a PhD student at the Technical University of Lisbon. During this time, he was also Teaching Assistant at Faculty of Sciences, University of Lisbon (1995-1999), Visiting Researcher at Department of Chemical and Nuclear Engineering, University of California,...

More

Nuno Correia Santos was born on July 17, 1972, in Lisbon, Portugal. In July, 1995, he received his 5-years degree in Biochemistry from the Faculty of Sciences, University of Lisbon. From 1994 to 1999, he worked as a PhD student at the Technical University of Lisbon. During this time, he was also Teaching Assistant at Faculty of Sciences, University of Lisbon (1995-1999), Visiting Researcher at Department of Chemical and Nuclear Engineering, University of California, Santa Barbara, USA (1997) and Assistant at Institute of Health Sciences (Lisbon) (1998-1999).

Nuno Santos received his Ph.D. in Biochemistry from the Faculty of Sciences, University of Lisbon, in November, 1999. Until 2000, he worked as Assistant at the Faculty of Medicine, University of Lisbon. That year, he became Assistant Professor in Faculty of Medicine, University of Lisbon, becoming a Researcher of the Institute of Molecular Medicine upon its creation. Since 2008, Nuno Santos is Head of the Biomembranes Unit, Institute of Molecular Medicine. His research focuses on biochemical and biophysical processes occurring at the level of the membranes of human cells, as well as of their viral and bacterial pathogens. Ongoing studies include:

1. The two steps of the life cycle of enveloped viruses (mainly HIV-1 and dengue virus) that involve biomembranes – the entrance of the virus or its content into the target cell and the assembly of new virions.

2. The pre-clinical evaluation of the membrane activity and mechanism of action at the molecular level of microbicides derived from natural antimicrobial peptides.

3. The binding of fibrinogen to the erythrocyte membrane and its relevance as cardiovascular risk factor.

4. The structural characterization of metal nanoparticles conjugated with proteins or nucleic acids, for biomedical application.

Nuno Santos is the author or co-author of more than 60 publications.

Less
1562105301_DrLuciaGemmaDelogu.jpg
Istituto di Ricerca Pediatrica Città della Speranza, Padua, Italy

Dr.  Lucia  Gemma  Delogu  has  been  an  Assistant  Professor  at  the University of Sassari (UNISS) since 2012. She received the Italian National Habilitation as an associate professor in Biochemistry.  She  leads  the  Laboratory  of  Bionanotechnology  in  the  Department  of Chemistry and Pharmacy (UNISS).  She received the title of Ph.D. in Biochemistry and...

More

Dr.  Lucia  Gemma  Delogu  has  been  an  Assistant  Professor  at  the University of Sassari (UNISS) since 2012. She received the Italian National Habilitation as an associate professor in Biochemistry.  She  leads  the  Laboratory  of  Bionanotechnology  in  the  Department  of Chemistry and Pharmacy (UNISS).  She received the title of Ph.D. in Biochemistry and Molecular Biology. She has worked as a postdoctoral fellow at the University of Southern California, Los Angeles (2007-2009) and was a visiting researcher at the Sanford-Burnham  Institute  of  San  Diego,  CA,  USA  in 2008  and  at  the Department of Health and Human Services at the NIH in Bethesda, MD in 2013. In  2011,  she  was  selected  as  one  of  the  “200  Best  Young  Talents  of  Italy”  from  the  Italian Ministry  of  Youth  (Rome, Italy). She has received several awards including the prestigious “Medicine, Biology e Nanotechnology Award” in 2012  from  the  Association  of  GianFranco  Del  Prete  and  the  “Bedside  to  bench  &  Back  Lecture  Series Achievement Award” National Institute of Health, Bethesda, USA (2013).

She is on the editorial board of the Journal of Translational Medicine. She is currently Visiting Professor under the “Eleonore Trefftz program Excellence in Science” at Technische Universitat  Dresden, Germany. Today,  Dr. Delogu’s laboratory focus on the study of nanomaterials in the biomedicine scenario, with aparticular emphasis on:

1) their interactions with the immune system;

2) their potential use as contrast agents;

3) their application in space biology;

Less
1562106112_ProfPaulaPereiraMarques.jpg
University of Aveiro, Portugal

Paula Marques (born 1969) is a Researcher at TEMA – Centre for Mechanical Technology and Automation, Mechanical Engineering Department, University of Aveiro (UA), since November 2007. She has a first degree in Chemistry in 1993, a MSc in Chemistry and Physics Teaching (1997) and a PhD in Materials Science Engineering, with specialization in Biomaterials (2003) from the University of Aveiro, having worked as a post-doctoral fellow at CICECO – Aveiro Institute...

More

Paula Marques (born 1969) is a Researcher at TEMA – Centre for Mechanical Technology and Automation, Mechanical Engineering Department, University of Aveiro (UA), since November 2007. She has a first degree in Chemistry in 1993, a MSc in Chemistry and Physics Teaching (1997) and a PhD in Materials Science Engineering, with specialization in Biomaterials (2003) from the University of Aveiro, having worked as a post-doctoral fellow at CICECO – Aveiro Institute of Materials, Department of Chemistry and Materials and Ceramic Engineering, UA.

Paula’s major domain of specialization comprise the engineering and development of new nanostructured materials. Presently, her main research interests comprise the use of graphene-based materials for applications, such as: (i) mechanical and electrical stimulus responsive 3D graphene-based scaffolds for tissue engineering; (ii) functional graphene-based macrostructures for water remediation; (iii) electrospun graphene/polymer fibres for photocatalysis; (iv) graphene-based materials as mechanical reinforcement of polymer matrixes.

Regarding Paula’s pedagogical experience, she is the teacher in charge for the curricular unit Carbon Nanostructures of the Doctoral Program in Nanosciences & Nanotechnology, and teacher of the curricular unit Processes and Technologies at Nano-Scale of the Master’s in Mechanical Engineering. Before and once graduated (1993) Paula was continuously involved in teaching activities as assistant lecturer teaching general chemistry laboratory classes in the Chemistry Department (UA.) In 2006, she joined the team of the coordinator in charge of the implementation of the Biomedical Sciences course at Secção Autónoma de Ciências da Saúde (SACS, UA) being responsible for the organization and teaching of biochemistry practical lessons (Da molécula ao Homem I e II) using the Problem Based Learning (PBL) approach.She is Visiting Professor at Luleå University of Technology, Sweden since January 2016. Concerning management activities at the academy, Paula is the Vice-Director of the Doctoral Program Nanoscience & Nanotechnology of the UA. She is Sub-Director of TEMA’s board of Directors, responsible for new areas of specialization. She was member of the scientific council (CC) and of the permanent commission of CC for the Human Resources of the UA and member of the Scientific Council an of the Scientific-Pedagogical Commission of Mechanical Engineering Department.

Less
1562203078_ProfSusanaGSantos.jpg
i3S - INEB, University of Porto, Portugal

Susana G. Santos did her basic degree in Biology and masters in Molecular Microbiology at the University of Aveiro, before moving to the University of Porto to do her PhD as part of the G.A.B.B.A. program. Her PhD was in the area of immunology, in a collaboration between ICBAS and IBMC at the University of Porto, Portugal and the College of Life Sciences at the University of Dundee, Scotland, UK. Then, she performed post-doctoral work in the Medical School, at St Andrews...

More

Susana G. Santos did her basic degree in Biology and masters in Molecular Microbiology at the University of Aveiro, before moving to the University of Porto to do her PhD as part of the G.A.B.B.A. program. Her PhD was in the area of immunology, in a collaboration between ICBAS and IBMC at the University of Porto, Portugal and the College of Life Sciences at the University of Dundee, Scotland, UK. Then, she performed post-doctoral work in the Medical School, at St Andrews University and later became a Medical Research Council (MRC) Career Development Fellow, at the MRC-Protein Phosphorylation Unit, College of Life Sciences in Dundee. At the end of 2008 she moved back to Porto to work at INEB, on the relation between inflammation and tissue regeneration. She is currently an Assistant Investigator at INEB-i3S, within the Microenvironments for NewTherapies Group. Her current research interests are in modulating the immune and inflammatory responses to develop new therapeutic strategies for tissue repair/regeneration. To accomplish that she has been working on: i) immune cells (e.g. macrophages and dendritic cells) and osteoclasts, their response to biomaterials and communication with bone marrow mesenchymal stem/stromal cells (MSC); ii) in vivo immune and regenerative responses to biomaterials for bone regeneration; iii) the role of extracellular vesicles (including exosomes) in cellular communication during inflammation resolution and tissue regeneration.

Less
1562106369_ProfSilviaMuro.jpg
Institut de Bioenginyeria de Catalunya (IBEC), Spain (To be confirmed)

Dr. Muro obtained her PhD in Sciences from Universidad Autónoma de Madrid and then moved to University of Pennsylvania as a Postdoctoral Associate and Research Assistant Professor in Pharmacology. In 2008 she joined the Bioengineering Department and the Institute for Bioscience and Biotechnology Research at the University of Maryland, where she was a tenured Associate Professor since 2012. Since November 2017, she is an ICREA Professor in the Institute for Bioengineering...

More

Dr. Muro obtained her PhD in Sciences from Universidad Autónoma de Madrid and then moved to University of Pennsylvania as a Postdoctoral Associate and Research Assistant Professor in Pharmacology. In 2008 she joined the Bioengineering Department and the Institute for Bioscience and Biotechnology Research at the University of Maryland, where she was a tenured Associate Professor since 2012. Since November 2017, she is an ICREA Professor in the Institute for Bioengineering of Catalonia. Dr. Muro has published 80+ articles and chapters in drug delivery and has received awards from the Controlled Release Society, the American Society for Nanomedicine, the UMD Outstanding Life Sciences Invention in 2011, the Junior Faculty Outstanding Engineering Research award, and is a member of the NIH Nanomedicine Study Section.

Dr. Muro's research sits at the interface between molecular-cellular biology and nanotechnology-drug delivery. Her lab studies the biological mechanisms ruling how our cells and tissues transport cargoes to precise destinations within our bodies, and then applies this knowledge toward the design of “biologically-controlled” nanodevices for improved delivery of therapeutic agents to specific disease sites. Focusing on genetic conditions that cause metabolic, neurodegenerative and cardiovascular syndromes, as well as on a new transport pathway she helped discover, her goal is to gain non-invasive, efficient, and specific access within the body and its cells, to enable effective treatment of these life-threatening disorders and other maladies characterized by similar pathological traits.

Less
1516893111_ProfValentinaCauda.jpg
Polytechnic University of Turin, Italy

Valentina Cauda is Associate Professor at the Department of Applied Science and Technology of the Politecnico di Torino, Italy since May 2016. She received her Ph.D. In Material Science and Technology in 2008 from the same university and graduated in Chemical Engineering in 2004. In 2006 she worked as visiting PhD student at the Universidad Complutense of Madrid, Spain in the research group of Prof. Maria Vallet-Regí. From 2008 to 2010, she worked as a Post-Doc...

More

Valentina Cauda is Associate Professor at the Department of Applied Science and Technology of the Politecnico di Torino, Italy since May 2016. She received her Ph.D. In Material Science and Technology in 2008 from the same university and graduated in Chemical Engineering in 2004. In 2006 she worked as visiting PhD student at the Universidad Complutense of Madrid, Spain in the research group of Prof. Maria Vallet-Regí. From 2008 to 2010, she worked as a Post-Doc at the Faculty of Chemistry, University of Munich, Germany in the group of Prof. Thomas Bein. From 2010 to 2015 she was Senior Post-Doc at the Istituto Italiano di Tecnologia in Turin, Italy. For her research results she received in 2010 the prize for young researchers at the Chemistry Department of the University of Munich, in 2013 she got the Giovedì Scienza award, in 2015 the Zonta Prize for Chemistry, and in 2017 the USERN Prize for Biological Sciences.In 2016 she was awarded by the European Research Council with an ERC Starting Grant entitled “TrojaNanoHorse”. She is author of 80 papers on peer-reviewed international journals with an H-index of 28 (Source: Scopus accessed on January 2018).

Less